ArticleGeroScience2025

The senolytic ABT-263 improves cognitive functions in middle-aged male, but not female, atherosclerotic LDLr

Mélanie Lambert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.